EMEA-000095-PIP02-21
Key facts
| Active substance |
Plitidepsin
|
|
| Therapeutic area |
Infectious diseases
|
|
| Decision number |
P/0544/2021
|
|
| PIP number |
EMEA-000095-PIP02-21
|
|
| Pharmaceutical form(s) |
Powder and solvent for concentrate for solution for infusion
|
|
| Condition(s) / indication(s) |
Treatment of Coronavirus disease 2019 (COVID-19)
|
|
| Route(s) of administration |
Intravenous use
|
|
| Contact for public enquiries |
Pharma Mar, S.A.
|
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|